HONG KONG, Dec. 12, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody. The study will compare cadonilimab plus chemotherapy against chemotherapy with or without nivolumab as first-line treatment for HER2-negative, unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma. This is the second international registrational study for cadonilimab, following
SINGAPORE, Dec. 12, 2025 -- Digital travel platform Agoda has curated a list of must-visit destinations across Asia where human creativity, architectural brilliance, and cultural heritage come together in unforgettable ways. From ancient capitals that feel like open-air museums to lantern-lit trading ports and lakeside palaces, these cities show how urban landscapes can tell powerful stories of both tradition and innovation. Travelers are increasingly seeking trips that go beyond checklists of attractions, looking instead to immerse themselves in the design, history, an
SEOUL, South Korea, Dec. 12, 2025 -- As the global CAD/CAM-based digital prosthetics market continues to grow rapidly, the importance of laboratories equipped with advanced automation and precision manufacturing capabilities is rising. Leaders Dental Laboratory is enhancing its competitiveness in the global digital prosthetics sector through its extensive clinical case experience and its mastery of advanced digital equipment operations. Specializing in CAD/CAM workflows, Leaders Dental produces high-precision zirconia crowns, bridges, and implant prosthetics based on detailed tooth mor
TOKYO, Dec. 12, 2025 -- The Herbalife Family Foundation (HFF), in partnership with LA Galaxy, hosted an outreach event at the Kobe Jitsugyo Gakuin (KJG) children's shelter. KJG is one of the nonprofit organizations participating in the Casa Herbalife Program, a global HFF initiative that provides children with access to nutritious meals, educational resources, and safe, nurturing environments. The event saw four LA Galaxy players including defenders Miki Yamane and Harbor Miller, and midfielders Tucker Lepley and Elijah Wynder who've dedicated time in their offseason to
[ 메디채널 김갑성 기자 ] After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body weight reductions of 7.72 kg and 8.65 kg. These results were significantly superior to those observed in the placebo group (BMI reduction: 1.73%; weight reduction: 1.42 kg; with nominal P values < 0.01). Furthermore, multiple metabolic parameters improved simultaneously. Mazdutide demonstrated a favorable overall safety and tolerability profile. All enrolled subjects completed the protocol-specified visits. Th
東京、2025年12月12日 — ハーバライフ・ファミリー・ファンデーション(HFF)は、LAギャラクシーと連携し、児童養護施設の神戸実業学院(KJG)で支援イベントを開催しました。KJGは、ハーバライフ・ファミリー・ファンデーションがグローバル規模で展開する支援活動であり、子どもたちに栄養価の高い食事、教育リソース、安全で養護的な環境を提供するカーサ・ハーバライフ・プログラム(Casa Herbalife Program)に参加している非営利組織の一つです。 このイベントには、LAギャラクシー所属の選手4名が参加し、ディフェンダーの山根視来選手、ハーバー・ミラー選手、ミッドフィルダーのイライジャ・ウィンダー選手、そしてフォワードのタッカー・レプリー選手、が、オフシーズンの時間を割いて子どもたちとの交流イベントに貢献しました。チームは、子どもたちの巧緻性や協調性を育むことを目的とした、楽しくスキルベースのサッカークリニックを実施しました。活気あふれる午後の時間を通じて、選手たちはポジティブな栄養の重要性を伝え、より健康的な生活を送るよう子どもたちを鼓舞することを目指しました。 「素晴らしい子どもたちとサッカーの楽しさを共有できたことは、本当に貴重な経験でした」とLAギャラクシーのディフェンダー、山根選手
SINGAPORE, Dec. 12, 2025 -- The Lions Club of Singapore Lotusia, in collaboration with MINDS Raintree Special Student Care Centre (SSCC), hosted "Little Hands, Big Joy", a Christmas celebration designed to bring joy, warmth and meaningful connection to 29 students with intellectual disabilities. This marks the second collaboration between the two organizations. During the celebration, the students created DIY Christmas socks, a hands-on festive activity designed to encourage enjoyment and self-expression. These socks are now showcased at Fernvale Community Club (CC) a
Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial Next steps include obtaining single IRB approval, site initiations and clinical start-up activities ahead of commencement of patient enrollment expected early in 2026 Milestone strengthens Neurizon's pathway toward advancing a potential new treatment for ALS MELBOURNE, Australia, Dec. 12, 2025 -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB
ABU DHABI, UAE, Dec. 12, 2025 -- ADGM, the international financial centre (IFC) of Abu Dhabi, in partnership with Global Climate Finance Centre (GCFC), Hanwha and the EU GCC Cooperation on green transition project, today hosted the 8th edition of the Abu Dhabi Sustainable Finance Forum (ADSFF). Held on the final day of ADFW, the forum brought together climate-finance leaders, innovators, policymakers and institutional investors, reinforcing Abu Dhabi's position as a global force in advancing the net-zero, nature-positive transition. Opening the forum, Salem Mohammed Al Darei, C
[ 메디채널 황정호 기자 ] His Excellency the Minister of Tourism and Chairman of the Board of Directors of the Saudi Fund for Development Inaugurates Day Three of the MOMENTUM 2025 Development Finance Conference RIYADH, Saudi Arabia, Dec. 12, 2025 -- [ 메디채널 황정호 기자 ] His Excellency the Minister of Tourism and Chairman of the Board of Directors of the Saudi Fund for Development, Mr. Ahmed Al Khateeb, inaugurated Day Three of the MOMENTUM 2025 Development Finance Conference, organized by the National Development Fund (NDF) under the patronage of His Royal Highness Prince Mohammed bin Salman bin